Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
U.S. Federal Trade Commission
Pharma
Trump's nominee to chair the FTC could bode well for pharma M&A
As Donald Trump fills out his cabinet, the President-elect’s latest pick could bode well for biopharma business development over the next four years.
Fraiser Kansteiner
Dec 11, 2024 11:25am
Biopharma status quo likely to persist under Trump 2.0: analyst
Nov 21, 2024 1:15pm
Roche CEO critiques Novo's proposed Catalent buyout
Oct 23, 2024 12:35pm
Warren challenges Novo Holdings' proposed Catalent buyout
Oct 10, 2024 2:16pm
Catalent reports upbeat Q4 results as it awaits review of sale
Aug 30, 2024 9:30am
Former FTC director weighs in on $16.5B Novo-Catalent deal
Jul 19, 2024 9:27am
